May 8, 2024 · Form 4 insider transaction
Kramer Kelly A. bought 12,648 shares of Gilead Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024.